XML 87 R61.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments in Nuclear Decommissioning Trusts and Other Special Use Funds (Tables)
12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Schedule of Fair Value of APS's Nuclear Decommissioning Trust Fund Assets
The following tables present the unrealized gains and losses based on the original cost of the investment and summarizes the fair value of the nuclear decommissioning trusts and other special use fund assets (dollars in thousands): 
December 31, 2024
 Fair ValueTotal
Unrealized
Gains
Total
Unrealized
Losses
Investment Type:Nuclear Decommissioning TrustsOther Special Use FundsTotal
Equity securities$435,470 $24,962 $460,432 $359,127 $(176)
Available for sale-fixed income securities844,040 355,544 1,199,584 (a)7,717 (31,960)
Other3,335 27,851 31,186 (b)— — 
Total$1,282,845 $408,357 $1,691,202 (c)$366,844 $(32,136)
(a)As of December 31, 2024, the amortized cost basis of these available-for-sale investments is $1,224 million.
(b)Represents net pending securities sales and purchases.
(c)All amounts pertain to APS, with the exception of $34 million of Other Special Use Fund investments in equity securities relating to the Captive.

December 31, 2023
 Fair ValueTotal
Unrealized
Gains
Total
Unrealized
Losses
Investment Type:Nuclear Decommissioning TrustsOther Special Use FundsTotal
Equity securities$420,680 $40,991 $461,671 $336,555 $— 
Available for sale-fixed income securities781,333 319,594 1,100,927 (a)21,518 (40,868)
Other(767)2,196 1,429 (b)39 — 
Total$1,201,246 $362,781 $1,564,027 (c)$358,112 $(40,868)
(a)As of December 31, 2023, the amortized cost basis of these available-for-sale investments is $1,120 million.
(b)Represents net pending securities sales and purchases.
(c)All amounts pertain to APS.
Schedule of Realized Gains and Losses and Proceeds from the Sale of Securities by the Nuclear Decommissioning Trust Funds
 Year Ended December 31,
 Nuclear Decommissioning TrustsOther Special Use FundsTotal
2024
Realized gains$75,690 $372 $76,062 
Realized losses$(21,966)$— $(21,966)
Proceeds from the sale of securities (a)$1,330,940 $355,154 $1,686,094 
2023
Realized gains$111,922 $172 $112,094 
Realized losses$(41,212)$(568)$(41,780)
Proceeds from the sale of securities (a)$1,324,978 $354,744 $1,679,722 
2022
Realized gains$9,017 $420 $9,437 
Realized losses$(40,239)$— $(40,239)
Proceeds from the sale of securities (a)$979,639 $227,558 $1,207,197 
(a)Proceeds are reinvested in the nuclear decommissioning trusts and other special use funds, excluding amounts reimbursed to the Company for active union employee medical claims from the active union employee medical account.
Schedule of Fair Value of Fixed Income Securities, Summarized by Contractual Maturities
The fair value of APS’s fixed income securities, summarized by contractual maturities, at December 31, 2024, is as follows (dollars in thousands):
 
 Nuclear Decommissioning TrustsCoal Reclamation Escrow AccountActive Union Employee Medical AccountTotal
Less than one year$19,868 $87,424 $39,090 $146,382 
1 year – 5 years268,974 58,598 154,768 482,340 
5 years – 10 years198,464 — 15,664 214,128 
Greater than 10 years356,734 — — 356,734 
Total$844,040 $146,022 $209,522 $1,199,584